BSEM - Company ID 0001658678
The table below shows BIOSTEM TECHNOLOGIES's income statement line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Revenue | $47.48M | $69.66M |
| Cost of revenue | $3.04M | $13.74M |
| Gross profit | $44.44M | $55.92M |
| R&D | $7.09M | $1.91M |
| SG&A | $23.79M | $18.80M |
| Operating income | -$689.15K | $31.12M |
| Income tax | $6.19M | -$496.85K |
| Net income | -$6.58M | $31.03M |
| EPS (diluted) | -$0.39 | $1.43 |
BIOSTEM TECHNOLOGIES reported annual revenue of $47.48M for fiscal year 2025. That is down 31.8% from $69.66M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.